NEUROD1 and Hyperglycemia: The total H3 also showed a subtle decrease at E18.5 consistent with what was observed at E14.5; however, at E16.5, an opposite trend was observed where H3 levels showed a modest increase in hyperglycemia on all promoters analyzed except Neurod1 (Fig 5A–C).